COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
30/08/2018
Multiple steps advance large-scale cannabis cultivation and position Emerald for industry-leading value-added manufacturing VICTORIA, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc [...]
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
30/08/2018
ALACHUA, Fla., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
Ogilvy CommonHealth Worldwide’s payer community flourishes with three executive level promotions
30/08/2018
PARSIPPANY, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW) ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP) ( www.wpp.com ), announced today the promotions of [...]
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
30/08/2018
CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Agility Health Reports Second Quarter 2018 Financial Results
30/08/2018
HAMILTON, Ontario, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or the “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, today [...]
On “Grindeks” Results in the First Six Months of 2018
30/08/2018
Turnover of “Grindeks” reaches 71.5 million euro in the first six months of 2018; profit – 6.7 million euro Today, on 30 August, the JSC “Grindeks” submitted the non-audited consolidated financial statements for the [...]
Two Global Cannabis Leaders Partnering to Bring Science-Based Innovations to the International Cannabis Marketplace -- CFN Media
30/08/2018
SEATTLE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Trillium to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
TORONTO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that it [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
30/08/2018
FIT Biotech Oy Company release August 30, 2018 at 04:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Mateon Therapeutics to Present at the Rodman & Renshaw Investor Conference on September 6, 2018
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing drugs for the treatment of orphan oncology indications, today announced it [...]
Digital Health Transformation Leader Daniel Garrett, Former PwC Partner, Joins Welldoc® Board of Directors
30/08/2018
BALTIMORE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Welldoc® , a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital therapeutics, announced today [...]
Trends to Watch as Cannabis Moves into the Health & Wellness Market -- CFN Media
30/08/2018
SEATTLE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Predictive Technology Group to Present at H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
SALT LAKE CITY, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, announces that Bradley Robinson, President and CEO, will present a corporate [...]
Captor Capital: A Hidden Gem Growing Quickly in the Attractive Cannabis Sector -- CFN Media
30/08/2018
SEATTLE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
ContraVir Pharmaceuticals Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018
30/08/2018
EDISON, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
CV Sciences, Inc. provides corporate update to shareholders
30/08/2018
LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like to assure our shareholders that we are keenly aware of recent market activity and [...]
ICC Labs Files Financial Results for the Second Quarter Ended June 30 and Completes the Construction of Its 124,000 sq. ft. Greenhouse in Colombia to Produce Psychoactive Medicinal Cannabis
30/08/2018
VANCOUVER, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ ICC Labs ” or the “ Company ”) (TSX-V: ICC) is pleased to announce that it has filed its interim financial results for the second quarter [...]
Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
RANCHO CORDOVA, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that [...]
Ultragenyx to Present at Upcoming Investor Conferences
30/08/2018
NOVATO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]

Pages